Yuki Kitano

17PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 06, 2026
Statin Use Is Associated With Improved Survival But Not Progression-Free Outcomes in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab-Bevacizumab.

|Jul 03, 2026
Preoperative Total Iron-Binding Capacity Is a Novel Surrogate Marker of Short- and Long-Term Outcomes After Liver Resection for Hepatocellular Carcinoma.

|Nov 25, 2025
High γ-H2AX Predicts Clinical Benefit From Platinum-Based Chemotherapy (mFOLFIRINOX) at Recurrence After Pancreatic Cancer Resection.

Takashi Matsumoto, Zhao Liu, Kosuke Kanemitsu

|Nov 07, 2025
Prognostic Impact of Hepatectomy Versus Radiofrequency Ablation for Non-Small Hepatocellular Carcinoma (2-3 cm): A Case-Matched Study.

Yuki Kitano, Hiromitsu Hayashi, Takumi Tanizaki

|Jul 18, 2022
Clinical impact of atrophic changes in remnant pancreas on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomy.

Kensuke Yamamura, Yo-Ichi Yamashita, Takanobu Yamao

|Jul 07, 2022
Impairment of perioperative activities of daily living is associated with poor prognosis following hepatectomy for hepatocellular carcinoma.

Kosuke Mima, Katsunori Imai, Takayoshi Kaida

Pageof 3

Frequent Collaborators

4 joint publications

Masaaki Iwatsuki

3 joint publications

Hiromitsu Hayashi

3 joint publications

Takashi Matsumoto

3 joint publications

Shigeki Nakagawa